Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
1.
Eur J Hum Genet ; 26(3): 350-358, 2018 03.
Artículo en Inglés | MEDLINE | ID: mdl-29330548

RESUMEN

Haploinsufficiency of the transcription factor short stature homeobox (SHOX) manifests as a spectrum of clinical phenotypes, ranging from disproportionate short stature and Madelung deformity to isolated short stature. Here, we describe five infants with molecularly confirmed diagnoses of SHOX haploinsufficiency who presented in utero with short long bones during routine antenatal scanning from as early as 19 weeks gestation. Other foetal growth parameters were normal. The molecular basis of SHOX haploinsufficiency was distinct in each case. In four cases, SHOX haploinsufficiency was inherited from a previously undiagnosed parent. In our de novo case, SHOX haploinsufficiency reflected the formation of a derivative sex chromosome during paternal meiosis. Final adult height in the SHOX-deficient parents ranged from -1.9 to -1.2 SDS. All affected parents had disproportionately short limbs and two affected mothers had bilateral Madelung deformity. To our knowledge, SHOX haploinsufficiency has not previously been reported to present in utero. Our experience illustrates that SHOX deficiency should form part of the differential diagnosis of foetal short long bones and suggests a low threshold for genetic testing. This should be particularly targeted at, but not limited to, families with a history of features suggestive of SHOX deficiency. Data on the postnatal growth of our index cases is presented which demonstrates that antenatal presentation of SHOX haploinsufficiency is not indicative of severe postnatal growth restriction. Early identification of SHOX deficiency will enable accurate genetic counselling reflecting a good postnatal outcome and facilitate optimal initiation of growth hormone therapy.


Asunto(s)
Huesos de la Extremidad Inferior/embriología , Huesos de la Extremidad Superior/embriología , Enfermedades Fetales/diagnóstico , Trastornos del Crecimiento/diagnóstico , Haploinsuficiencia , Osteocondrodisplasias/diagnóstico , Fenotipo , Proteína de la Caja Homeótica de Baja Estatura/genética , Adulto , Huesos de la Extremidad Inferior/diagnóstico por imagen , Huesos de la Extremidad Superior/diagnóstico por imagen , Diagnóstico Diferencial , Femenino , Enfermedades Fetales/genética , Trastornos del Crecimiento/genética , Humanos , Masculino , Osteocondrodisplasias/genética , Linaje , Embarazo , Segundo Trimestre del Embarazo , Tercer Trimestre del Embarazo , Ultrasonografía Prenatal
2.
Br J Hosp Med (Lond) ; 69(7): 388-91, 2008 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-18833968

RESUMEN

Electronic fetal heart rate monitoring is a useful monitoring tool to assess intrapartum fetal wellbeing and has been shown to improve perinatal outcomes in at-risk fetuses. This article describes the benefits, criticisms of its use during labour, the pathophysiology and care pathway based on the cardiotocogram features.


Asunto(s)
Cardiotocografía , Sufrimiento Fetal/diagnóstico , Frecuencia Cardíaca Fetal/fisiología , Complicaciones del Embarazo/fisiopatología , Femenino , Sufrimiento Fetal/fisiopatología , Humanos , Embarazo , Atención Prenatal/métodos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA